Literature DB >> 15196072

Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C.

Mark W Russo1, Joseph A Galanko, Steven L Zacks, Kimberly L Beavers, Michael W Fried, Roshan Shrestha.   

Abstract

Studies suggest donor age and year of transplantation are associated with low graft survival in liver transplant recipients with hepatitis C. We sought to determine if advanced donor age and recent year of transplantation are associated with graft survival in hepatitis C recipients and to determine if the effect of donor age on graft survival is specific to hepatitis C. We analyzed the United Network for Organ Sharing liver transplant database from 1994 to 2002. Six thousand four hundred and four subjects transplanted for end-stage liver disease from chronic hepatitis C met our criteria. One-year graft survival in hepatitis C recipients with organs from donors <40 years old and >or=60 years old was 84% and 73%, p = 0.003, respectively. These rates in recipients with cholestatic liver disease and alcoholic liver disease were 85% and 82%, respectively, p = 0.11 and 82% and 78%, respectively, p = 0.14. Three-year graft survival in hepatitis C recipients transplanted from 1994 to 1995 and 1996 to 1999 was 67% and 69%, respectively, p = 0.10. Graft survival in hepatitis C recipients has not declined in recent years. Older donor age is associated with lower short-term graft survival in recipients with hepatitis C, but not in recipients with cholestatic or alcoholic liver disease.

Entities:  

Mesh:

Year:  2004        PMID: 15196072     DOI: 10.1111/j.1600-6143.2004.00470.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

Review 1.  Liver transplantation for hepatitis C virus related liver disease.

Authors:  I Gee; G Alexander
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 2.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.

Authors:  Gamal Shiha; Alaa Ibrahim; Ahmed Helmy; Shiv Kumar Sarin; Masao Omata; Ashish Kumar; David Bernstien; Hitushi Maruyama; Vivek Saraswat; Yogesh Chawla; Saeed Hamid; Zaigham Abbas; Pierre Bedossa; Puja Sakhuja; Mamun Elmahatab; Seng Gee Lim; Laurentius Lesmana; Jose Sollano; Ji-Dong Jia; Bahaa Abbas; Ashraf Omar; Barjesh Sharma; Diana Payawal; Ahmed Abdallah; Abdelhamid Serwah; Abdelkhalek Hamed; Aly Elsayed; Amany AbdelMaqsod; Tarek Hassanein; Ahmed Ihab; Hamsik GHaziuan; Nizar Zein; Manoj Kumar
Journal:  Hepatol Int       Date:  2016-10-06       Impact factor: 6.047

4.  Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Authors:  Sinziana Dumitra; Salleh I Alabbad; Jeffrey S Barkun; Teodora C Dumitra; Dimitrios Coutsinos; Peter P Metrakos; Mazen Hassanain; Steven Paraskevas; Prosanto Chaudhury; Jean I Tchervenkov
Journal:  HPB (Oxford)       Date:  2013-03-14       Impact factor: 3.647

5.  Association of age-dependent liver injury and fibrosis with immune cell populations.

Authors:  Bradley H Collins; Zoie E Holzknecht; Kellie A Lynn; Gregory D Sempowski; Catherine C Smith; Songling Liu; William Parker; Don C Rockey
Journal:  Liver Int       Date:  2013-05-26       Impact factor: 5.828

6.  Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

Authors:  Carlos Jiménez-Romero; Marta Clemares-Lama; Alejandro Manrique-Municio; Alvaro García-Sesma; Jorge Calvo-Pulido; Enrique Moreno-González
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.